777 related articles for article (PubMed ID: 17919774)
1. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.
White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A
J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients.
Mulyowa GK; Jaeger G; Kabakyenga J; Bröcker EB; Zillikens D; Schmidt E
Int J Dermatol; 2006 Sep; 45(9):1047-52. PubMed ID: 16961507
[TBL] [Abstract][Full Text] [Related]
3. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
5. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
[TBL] [Abstract][Full Text] [Related]
8. Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies.
Wakelin SH; Bhogal B; Black MM; Allen J; Wojnarowska F; Hashimoto T; Farr PM; Swain AF
Br J Dermatol; 1997 Apr; 136(4):604-9. PubMed ID: 9155969
[TBL] [Abstract][Full Text] [Related]
9. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
Dilling A; Rose C; Hashimoto T; Zillikens D; Shimanovich I
J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
[TBL] [Abstract][Full Text] [Related]
10. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
Chan LS; Cooper KD
Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
[TBL] [Abstract][Full Text] [Related]
11. A case of generalized pustular psoriasis followed by bullous disease: an atypical case of bullous pemphigoid or a novel bullous disease?
Saeki H; Hayashi N; Komine M; Soma Y; Shimada S; Watanabe K; Hashimoto T
Br J Dermatol; 1996 Jan; 134(1):152-5. PubMed ID: 8745904
[TBL] [Abstract][Full Text] [Related]
12. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
Billet SE; Kortuem KR; Gibson LE; El-Azhary R
Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
[TBL] [Abstract][Full Text] [Related]
13. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature.
Vodegel RM; de Jong MC; Pas HH; Jonkman MF
J Am Acad Dermatol; 2002 Dec; 47(6):919-25. PubMed ID: 12451379
[TBL] [Abstract][Full Text] [Related]
14. Pure ocular cicatricial pemphigoid. A distinct immunopathologic subset of cicatricial pemphigoid.
Hoang-Xuan T; Robin H; Demers PE; Heller M; Toutblanc M; Dubertret L; Prost C
Ophthalmology; 1999 Feb; 106(2):355-61. PubMed ID: 9951490
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
16. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
17. A bullous skin disease patient with autoantibodies against separate epitopes in 1 mol/L sodium chloride split skin.
Domloge-Hultsch N; Benson P; Gammon WR; Yancey KB
Arch Dermatol; 1992 Aug; 128(8):1096-101. PubMed ID: 1379792
[TBL] [Abstract][Full Text] [Related]
18. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; Bröcker EB; Hashimoto T
J Invest Dermatol; 1996 Mar; 106(3):465-70. PubMed ID: 8648178
[TBL] [Abstract][Full Text] [Related]
19. Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease.
Lally A; Chamberlain A; Allen J; Dean D; Wojnarowska F
Clin Exp Dermatol; 2007 Sep; 32(5):493-8. PubMed ID: 17459072
[TBL] [Abstract][Full Text] [Related]
20. A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions.
Olivry T; Dunston SM; Schachter M; Xu L; Nguyen N; Marinkovich MP; Chan LS
J Autoimmun; 2001 Jun; 16(4):411-21. PubMed ID: 11437489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
